HR-4346-117
Became Public Law No: 117-167.
What it does
The CHIPS and Science Act does three main things: it provides direct federal funding and a 25% tax credit to incentivize companies to build semiconductor manufacturing facilities in the United States; it establishes several federal funds for semiconductor workforce development, supply chain security, and international technology partnerships; and it authorizes large-scale funding for federal science agencies — including the Department of Energy and the National Science Foundation — to conduct research in areas such as quantum computing, artificial intelligence, fusion energy, and particle physics. The law also includes provisions to promote participation by minority-owned, women-owned, and veteran-owned businesses in funded programs.
Who benefits
Domestic semiconductor manufacturers (e.g., Intel, TSMC U.S. operations, Micron) that receive direct subsidies and tax credits. Construction workers and tradespeople who build new fabrication plants. STEM workers and students, particularly those from Historically Black Colleges and Universities, Hispanic-serving institutions, Tribal Colleges, and community colleges, who gain access to new training and research programs. Defense and national security agencies that depend on secure domestic chip supply chains. Startups and small businesses in the microelectronics sector. Minority-owned, women-owned, and veteran-owned businesses targeted by inclusion provisions. Researchers at national laboratories and universities receiving expanded DOE and NSF funding. Medical and industrial sectors that rely on isotope production. Consumers and industries broadly, to the extent domestic chip supply reduces future shortages like those experienced during 2020–2022.
Who is hurt
Foreign semiconductor manufacturers — particularly those in Taiwan, South Korea, and China — that may lose U.S. market share or face competitive disadvantage. U.S. companies that currently source chips from lower-cost foreign suppliers and may face higher prices if domestic production costs are passed through. Taxpayers who bear the cost of the estimated $52 billion in direct semiconductor subsidies and hundreds of billions in science authorizations. Foreign-owned firms that are effectively excluded from receiving financial assistance (funds may not be used to build facilities outside the U.S.). Companies that receive federal assistance face restrictions on expanding advanced chip manufacturing in China for 10 years, which may constrain their global business strategies. Existing chip manufacturers not selected for grants who may face newly subsidized competition.
Supporters argue
Supporters argue that the United States' share of global semiconductor manufacturing fell from 37% in 1990 to roughly 12% by 2020, creating dangerous dependence on foreign — particularly Taiwanese — production for chips that power everything from cars to weapons systems. They contend the 2020–2022 chip shortage cost the U.S. auto industry alone an estimated $210 billion in lost revenue, demonstrating the real economic and national security cost of supply chain fragility. Supporters further argue that competitor nations, especially China, have invested hundreds of billions in state-subsidized chip production, and that without comparable federal support, U.S. manufacturers cannot compete on cost alone.
Opponents argue
Opponents argue that the bill amounts to large-scale corporate welfare — directing tens of billions in taxpayer funds to profitable multinational corporations that would likely have invested in U.S. capacity anyway given market incentives. They contend that government-directed industrial policy has a poor track record of efficiently allocating capital, citing examples like Solyndra, and that the 25% manufacturing tax credit and direct grants distort market competition in ways that may entrench incumbents and crowd out innovative new entrants. Opponents further argue that the bill's restrictions on recipients expanding operations in China may provoke retaliatory trade measures and disrupt global supply chains that U.S. companies depend on.
Constitutional context
The bill rests primarily on Congress's Commerce Clause authority (Art. I, §8, cl. 3) to regulate interstate and foreign commerce, and its spending power to fund research and provide conditional grants to private entities. No significant Fourth Amendment or First Amendment issues are raised. Post-Loper Bright (2024), any agency regulations implementing the grant conditions and tax credit program would face independent judicial scrutiny rather than automatic deference, which could affect how Commerce and Treasury implement the bill's more ambiguous provisions.
Checks and balances
The executive branch — primarily the Department of Commerce and Department of Energy — gains significant discretionary authority to award grants and set conditions; Congress retains oversight through GAO review requirements, annual reporting mandates, and its appropriations power.
Historical precedent
The CHIPS Act broadly resembles the Sematech consortium of the late 1980s, in which the federal government provided $100 million annually to a public-private semiconductor research partnership to counter Japanese competition, a program credited with helping restore U.S. chip competitiveness in the 1990s.